鸡软骨细胞体外分离培养鉴定以及过表达miR-15a对软骨细胞的影响

为分析miR-15a在肉鸡不同组织中的表达情况,并探究过表达miR-15a对体外培养鸡软骨细胞的影响。本研究首先通过倒置显微镜观察、PCR、凝胶电泳和甲苯胺蓝染色对体外分离培养的软骨细胞进行鉴定。通过实时荧光定量PCR检测miR-15a在肢体内外翻畸形(valgus-varus deformity, VVD)组和健康组肉鸡中(各3只)各组织的表达量。之后通过CCK8和EDU方法分析软骨细胞过表达miR-15a后细胞增殖情况。软骨细胞转染miR-15a mimics后,通过qPCR检测软骨细胞的标志基因Collagen-2、Aggrecan、Collagen-10,成熟分化基因Runx2、Sox9、VEGF、MMP9,炎性因子IL-1β、IL-6、IL-8、IL-10、TNF-α、TGF-β3以及凋亡基因Fas、FasL、Bcl-2的表达量。并构建FKBP5 3'UTR的野生型载体和突变型载体,通过双荧光素酶检测报告检测miR-15a与FKBP5的靶向关系。结果表明,本研究所用的胰蛋白酶、Ⅱ型胶原酶和透明质酸酶联合消化法成功分离得到状态良好的软骨细胞。荧光定量结果显示,miR-15a在各组织中均有表达,与健康组相比,miR-15a在VVD组的肝(P < 0.01)、脾(P < 0.05)、胸腺(P < 0.01)中的表达量显著升高,在心和胸肌组织中的表达量显著降低(P < 0.01)。CCK8与EDU分析结果显示,与NC组相比,过表达miR-15a组软骨细胞增殖速度显著降低(P < 0.01),增殖细胞数量显著减少(P < 0.01)。qPCR结果显示,与mimics NC组相比,miR-15a mimics组的软骨细胞标志基因Aggrecan、成熟分化基因Sox9、Runx2表达量显著降低(P < 0.05),Fas基因表达量极显著上升(P < 0.01),FasL基因和抗凋亡基因Bcl-2极显著下降(P < 0.01)。成功构建了FKBP5 3'UTR野生型和突变型载体,双荧光素酶检测报告结果显示预测的靶基因FKBP5与miR-15a没有靶向关系。本研究成功分离并鉴定了鸡软骨细胞,过表达miR-15a抑制鸡软骨细胞增殖、成熟和分化并促进细胞凋亡。     

铜对体外仔猪软骨细胞增殖和细胞骨架的影响

体外分离、培养仔猪关节软骨细胞,在细胞培养液中分别添加铜0、7.8、15.6、31.2、62.5μmol/L。结果表明,软骨细胞在4种铜浓度中可存活并增殖,但随铜浓度的增加,其存活率、增殖率、3H-TdR掺入率有明显的差异,且能破坏软骨细胞骨架。培养液中添加铜31.2μmol/L,对软骨细胞的增殖作用最强,增殖率、3H-TdR掺入数显著高于对照组(P<0.01),软骨细胞形态及骨架均正常。表明31.2μmol/L铜浓度是促进体外软骨细胞增殖的最适浓度。     

探讨不同浓度碘乙酸钠对家兔早期膝关节骨性关节炎模型的诱导及病理改变

目的 探讨不同浓度碘乙酸钠对家兔早期膝骨性关节炎（osteoarthritis,OA）模型的诱导及病理改变,确定建立OA模型的最小有效药物浓度。方法 将36只新西兰大白兔随机分为正常（A）组、模型（B~F）组,共6组,每组6只。A组左膝关节腔注射0.2 mL无菌生理盐水;B~E组左膝关节腔按照2.5、5、7.5、10 mg/kg剂量各注射0.2 mL的碘乙酸钠溶液,F组注射剂量与E组相同,同时以30 min/d分2次驱赶运动为干预因素。建模14 d后,采用HE染色及骨性关节炎组织病理学评分（Mankin评分）观察各组软骨的病理改变。结果 Mankin评分与A组相比,B、C组差异无统计学意义（P>0.05）,D、E、F组差异有统计学意义（P<0.05）;与E组比较,F组差异无统计学意义（P>0.05）。结论 模型D组药物浓度7.5 mg/kg为建立OA模型的最小有效药物剂量,且模型建立方法操作简单、创伤小,能够保证膝关节稳定性及实验动物的成活率。     

肉鸡骨骼发育的调控机制

肉鸡骨骼发育主要是通过软骨内骨化完成的。在软骨内骨化的进程中,生长板软骨细胞经历增殖、肥大、转分化和软骨基质矿化等,最终成骨逐渐取代软骨原基,实现骨骼的线性延长。软骨内成骨是一个复杂精密的过程,由SOX9、RUNX2、MEF2C、OSX、TGF-β、BMP2、FGFs、IHH和PTHrP等多种信号因子和转录因子协调调控,这些调控因子由生长板不同区的软骨细胞表达或特异性的调控软骨细胞的增殖、分化及血管侵入等过程。在家禽养殖中,肉鸡常发腿病且治疗难度大,而有关肉鸡腿病发病机制的研究报道相对较少。本文综述了骨形成过程及具体的分子调控机制,为了解肉鸡腿病的发生以及提供有效治疗方案提供参考。     

蚕丝及Ⅱ型胶原凝胶支架负载软骨细胞构建组织工程类软骨

观察软骨细胞在蚕丝及胶原凝胶2种支架上生长状态,为软骨组织工程支架选择提供依据。将体外第2代兔关节软骨细胞接种于蚕丝和Ⅱ型胶原凝胶,倒置显微镜下观察软骨细胞在支架内的生长增殖状况,并对细胞-支架复合物进行组织切片观察。结果显示,经胶原包被后的蚕丝对软骨细胞表现出良好的吸附作用,并有利于软骨细胞的生长增殖。在培养初期,蚕丝内细胞生长增殖较胶原凝胶内的慢,但随后随着胶原支架的缀陵降解细胞增殖速度减慢,而蚕丝上的细胞数量仍在增加。该研究表明软骨细胞在蚕丝和胶原凝胶两种支架上都能维持正常生长状态,但蚕丝作戈、软骨组织工程支架在长期效果优于胶原凝胶。     

Treatment of subchondral cystic lesions of the medial femoral condyle of mature horses with growth factor enhanced chondrocyte grafts: a retrospective study of 49 cases

Reasons for performing study: To evaluate the long‐term clinical outcome after allogeneic chondrocyte and insulin‐like growth factor‐I (IGF‐I) grafting of subchondral cystic lesions (SCLs) of the femoral condyle in horses. Objective: To test the hypothesis that chondrocyte and IGF‐I grafts will improve the long‐term clinical outcome in arthroscopically debrided SCLs. Methods: Medical records of 49 horses with SCLs of the femoral condyle treated by debridement and implantation of chondrocytes and IGF‐I were reviewed. Preoperative radiographs were obtained, and caudocranial radiographic projections were used to establish a ratio between cyst and femoral condyle size. Arthroscopic cyst debridement followed by filling of the bone void with autologous cancellous bone (45 horses) or tricalcium phosphate granules (4 horses) was performed. A paired syringe containing a fibrinogen and chondrocyte mixture in one syringe and calcium‐activated bovine thrombin with IGF‐I in the other was used to cover the surface. A successful outcome was defined as a horse that performed to its intended use without lameness. Results: A successful outcome was achieved in 36 of 49 horses (74%). Preoperative radiography was performed in all horses, with 33 horses having unilateral SCLs of the medial femoral condyle, 15 horses having bilateral SCLs of the medial femoral condyle, and one horse having bilateral SCLs of the lateral femoral condyle. Median age of the horses was 3.3 years. Fifteen horses had preoperative radiographic and arthroscopic evidence of osteoarthritis (OA). A successful outcome was not influenced by age of horse, presence of pre‐existing osteoarthritis or preoperative size of the subchondral cyst. Grafting resulted in success for 80% of horses >3 years old, and in 80% of horses with OA. Conclusions: Implantation of allogeneic chondrocytes supplemented with IGF‐I is an effective treatment for horses with SCLs of the femoral condyle, and particularly for older horses and horses with pre‐existing osteoarthritis. Potential relevance: Chondrocyte implantation may offer a greater chance of long‐term success in older horses and horses with osteoarthritis than has been previously reported with cyst debridement alone.     

Immunolocalization of cathepsin B in equinedyschondroplastic articular cartilage

A polyclonal antiserum raised in sheep against human cathepsin B was tested for specificity and cross-reactivity with the horse homologue by SDS-PAGE and Western blotting, prior to being used for immunolocalization of the enzyme in equine articular cartilage. In Western blots, the antiserum recognized the 30 kDa single chain and 25 kDa heavy chain of the mature enzyme in purified bovine cathepsin B, and corresponding bands at 32 and 27 kDa in equine chondrocyte and fibroblast lysates. This antiserum was then used to compare the expression and distribution of cathepsin B in normal and dyschondroplastic cartilage of young horses.In normal articular cartilage (n=6 animals), significant amounts of enzyme were detected only in hypertrophicchondrocytes in the deep zone. The enzyme was intracellular, located in the lysosomal granules. No extracellular matrix staining was observed. Levels of cathepsin B were increased slightly above normal in the deep zone in age-matched dyschondroplastic cartilage (n=5 animals). The most striking finding, however, was the abundance of the enzyme in chondrocyte clonal clusters associated with the lesions. Cathepsin B levels were low in chondrocytes isolated from normal cartilage (n=6), but increased progressively during serial subculture, reaching a maximum at passage 5–6. In contrast, primary cultures of dyschondroplastic chondrocytes (n=3) expressed abundant cathepsin B.     

雌激素与尼古丁对软骨细胞基质代谢影响

雌激素和尼古丁是2种对骨关节炎发病有影响的重要因素,但其影响的具体分子机制仍然存在争议。本研究旨在探讨这2种因素单独和叠加对软骨细胞代谢的影响,从而为骨关节炎的发病机制研究提供一定的参考。鼠胚胎瘤来源的软骨前体细胞系ATDC5在进行铁硒传递蛋白ITS定向诱导能够分化为软骨细胞。研究中对诱导后获得的软骨细胞用雌激素及尼古丁进行了处理。处理后细胞胞外基质蛋白聚糖和二型胶原表达水平分别用甲苯胺蓝染色和免疫组化进行检测,蛋白表达水平和mRNA水平分别进行了Western blot和Real-time PCR验证。研究结果显示尼古丁会造成软骨细胞2种胞外基质分泌的降低,并且促进分解酶MMP13的表达,抑制合成相关蛋白BMP-7的表达。而雌激素能够通过抑制分解酶MMP13和促进基质合成相关蛋白BMP-7的表达来挽回尼古丁对软骨细胞胞外基质的破坏作用。但在mRNA水平,与仅用尼古丁处理相比,雌激素会同时促进mmp13和bmp-7的表达,推测是因为雌激素增强了细胞的代谢效率。这些结果表明,雌激素对受到尼古丁影响的软骨细胞具有保护作用,这可能是骨关节炎初期防治的一个潜在治疗方案。     

Iksan526 Rice Callus Extract Induces Dedifferentiation of Rabbit Articular Chondrocytes via ERK1/2 and PI-3K/Akt Pathways

The resveratrol-enriched transgenic rice line Iksan526 (IS526), first developed by the Rural Development Administration of Korea using genetic engineering techniques, shows beneficial health effects in mitigating metabolic syndrome and obesity. However, the effects of IS526 on the differentiation of chondrocytes and the underlying mechanism have not been investigated in detail. In this study, the effects and cellular regulatory mechanisms of IS526 on rabbit articular chondrocytes were examined. Following IS526 callus extract treatment, the expression levels of differentiation-related proteins were detected via western blotting, Alcian blue staining and immune-luorescence staining. IS526 decreased the type II collagen and proteoglycan levels in dose- and time-dependent manners. We further analyzed the effects of IS526 on skeleton genesis in zebrafish larvae using Alcian blue staining, which showed a reduction in cartilage formation along with increased production of matrix metalloproteinase (MMP)-13. IS526 also increased the phosphorylation of ERK1/2 and p38 kinase but inhibited the phosphorylation of Akt. Pharmacological inhibition of MMP-13 blocked the IS526-induced decrease in type II collagen levels. Inhibition of p38 kinase or PI-3K/Akt with SB203580 and LY294002 enhanced the suppression of type II collagen, but the blockage of ERK-1/2 by PD98059 rescued IS526-induced dedifferentiation. These results suggested that IS526 regulates type II collagen and MMP-13 expression via the ERK1/2 and PI-3K/Akt pathways in rabbit articular chondrocytes.     

Primary Cilia in Chondrogenic Differentiation of Equine Bone Marrow Mesenchymal Stem Cells: Ultrastructural Study

Locomotor system disorders in equine species, such as tendon lesions, osteoarthritis, or ligament injuries, are some of the most frequent causes of dramatic reduction in horse performance. Traditional therapies are aimed at the inflammatory process and pain, but they do not regenerate normal tendon or ligament matrix and do not reduce re-injured rates. Mesenchymal stem cells have started to use as therapeutic option to repair these injured tissues. Most studies have focused on their isolation, in vitro culture and phenotyping. However, mesenchymal stem cell ultrastructure has been disregarded in the last years. We investigate the ultrastructural characteristics of these cells once differentiated into chondrocytes. Ultrastructural analysis was conducted on suspension cultures of differentiated chondrocytes from bone marrow mesenchymal stem cells by means of transmission electron microscopy. The morphologic characteristics of these cells, their ability to produce the extracellular matrix, and the presence of a single cilium could be indicative of the mesenchymal cells differentiation into chondrocyte phenotype. This study provides essential data to evaluate the degree of suitable phenotypic stability, for these cells can be used with repair purposes.